Judge Shoots Down BI Lawsuit, Possibilities Dwindling For Remaining IRA Cases

By Gabrielle Wanneh / July 8, 2024 at 6:10 PM
A Connecticut district court judge last week rejected Boehringer Ingelheim’s lawsuit against Medicare drug price negotiation, marking the fifth lawsuit against the Inflation Reduction Act program to be shot down at the district level, lessening the chances of the drug industry receiving a win that could potentially propel the issue to the Supreme Court. Rejecting BI’s claims that the drug price negotiation program violates the First Amendment and multiple clauses of the Fifth Amendment, the judge ruled that the company’s...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.